Author: healthadmin
Recent research published in journals deviant behavior Mapping the warning signs and organizational flaws that precede a deadly attack by a man who identifies as an involuntary bachelor. Researchers worked backwards from four different tragedies to identify a chain of severe social isolation, untreated mental health problems, and missed opportunities for intervention. These insights provide a roadmap for recognizing the red flags of misogynistic extremism and deterring future acts of mass violence. The Internet is home to a vast number of communities, some of which are united by common grievances. One such group is the “incel” subculture. This is a…
A federal judge in Boston on Monday stalled a key part of Health Secretary Robert F. Kennedy Jr.’s campaign to reshape U.S. vaccine policy, saying the Trump administration likely violated the law. Judge Brian E. Murphy issued a preliminary ruling that President Kennedy’s reconstitution of a key vaccine advisory committee and changes to the childhood vaccination schedule made in January were likely illegal. Specifically, the court ruled that these policy changes violated the Administrative Procedure Act, which governs how federal agencies should consider and implement policy changes. The decision is not final, but it is a blow to the Trump…
A longitudinal study of infants aged 12 to 18 months found that higher skin carotenoid concentrations at the start of the study predicted trends in improved cognitive development by 30 months. These infants also showed significant improvements in fine motor skills throughout the 12-month period, and improved ability to understand spoken language later in this period. The study was published in the Journal of Cognitive Enhancement. Skin carotenoids are natural pigments that accumulate in human skin after being ingested in the diet. They are primarily obtained from fruits and vegetables rich in carotenoids, such as carrots, sweet potatoes, spinach, and…
A compound in cannabis may help reduce alcohol dependence and withdrawal symptoms, a new study in animals suggests that the substance can protect the brain from damage caused by heavy drinking. This study was published in the journal neuropsychopharmacology. Alcoholism remains a serious global health problem. People with alcohol use disorders often struggle with uncontrolled drinking and experience severe withdrawal symptoms when they try to quit. Several medications exist to help treat alcohol dependence, but many have limited effectiveness or cause unwanted side effects. A potential alternative is cannabidiol (CBD), a natural compound found in the cannabis plant. Unlike THC,…
In February, the African Center for Biodiversity (ACB) released a report documenting glyphosate concentrations in wheat and corn that exceeded default maximum residue limits. ACB also found traces of the herbicide in bread and baby cereal. “It was very disturbing to find glyphosate in baby cereals. Babies are the most vulnerable and it shouldn’t be there. We know glyphosate is an endocrine disruptor, so if you’re giving this to young babies every day, that’s very problematic. It can affect their physical health and development,” ACB research coordinator Zakiyah Ismail said in a phone call with Mongabay. Following this…
The transfer of federal forest land in Arizona to two international companies planning to mine one of North America’s largest copper deposits has been completed, but a group of Apache women is asking the U.S. Supreme Court to intervene as a last resort to block the project. Title to the land was conveyed to Resolution Copper by the federal government on Friday after an appeals court denied a request by the San Carlos Apache Tribe and environmentalists to block the removal.The Court of Appeals reversed the appellate court’s decision, finding that the plaintiffs’ legal claims were unlikely to succeed. emergency…
Updated: March 16th 12:20pm ET The Trump Administration has launched grant applications for a new model aimed at providing Medicare coverage to functional medicine and lifestyle health care providers. The Centers for Medicare and Medicaid Services released “Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE)” in December. Participants seeking grants under this model must submit a letter of intent by April 10th, with the final application deadline set for May 15th. In a funding notice issued March 13, the agency said it has selected 30 participants for the model and will receive a total…
In a clinical trial supported by the National Institutes of Health (NIH), researchers found that weekly injections of extended-release buprenorphine to treat opioid use disorder (OUD) during pregnancy resulted in higher rates of abstinence from illicit opioids than daily sublingual (sublingual) administration of buprenorphine, one of the standard treatments. Additionally, serious adverse events were less common in patients receiving extended-release therapy. Research findings support the use of this formulation of buprenorphine in the treatment of OUD during pregnancy. JAMA Internal Medicine. These findings are clinically valuable as they demonstrate that this injectable extended-release buprenorphine formulation can be safely used…
Type 2 diabetes (T2D) and obesity are metabolic diseases with many causes, including overlapping and distinct genetic features. Polygenic risk scores (PRS) capture multiple genetic risk factors and can estimate whether a person is likely to develop a complex medical condition and how they will cope in the long term. Researchers at Massachusetts General Brigham have built a metabolic PRS to predict obesity and T2D by integrating genetic findings from some of the world’s largest biobanks. It outperformed existing disease prediction models and predicted downstream morbidity and clinical interventions. The survey results are posted below cell metabolism. Our aim…
BioMarin is focused on its CNP analog, Voxzogo, to write the next chapter of the company’s growth story, but changes to its clinical development plan are adding further uncertainty to the company’s calculations. BioMarin will discontinue dosing and enrollment in its Phase 2 trial of Voxzogo, currently approved for achondroplasia, a form of dwarfism, in three potential indications: Turner syndrome, SHOX deficiency, and aggrecan (ACAN) deficiency. The move follows reports of “several” slipped femoral epiphysis (SCFE) events, in which the femoral head slips out of place, in two investigator-initiated trials of the drug, BioMarin said in a March 16 securities…